Production (Stage)
iHuman Inc.
IH
$2.26
-$0.03-1.31%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -6.25% | -6.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -6.25% | -6.25% |
| Cost of Revenue | -- | -- | -- | -9.72% | -9.72% |
| Gross Profit | -- | -- | -- | -4.77% | -4.77% |
| SG&A Expenses | -- | -- | -- | 10.88% | 10.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -2.59% | -2.59% |
| Operating Income | -- | -- | -- | -26.15% | -26.15% |
| Income Before Tax | -- | -- | -- | -11.80% | -11.80% |
| Income Tax Expenses | -- | -- | -- | -47.32% | -47.32% |
| Earnings from Continuing Operations | -- | -- | -- | -4.60% | -4.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -- | -- | -4.60% | -4.60% |
| EBIT | -- | -- | -- | -26.15% | -26.15% |
| EBITDA | -- | -- | -- | -23.47% | -23.47% |
| EPS Basic | -- | -- | -- | -3.91% | -3.91% |
| Normalized Basic EPS | -- | -- | -- | -27.23% | -27.23% |
| EPS Diluted | -- | -- | -- | -7.10% | -7.10% |
| Normalized Diluted EPS | -- | -- | -- | -28.12% | -28.12% |
| Average Basic Shares Outstanding | -- | -- | -- | -0.79% | -0.79% |
| Average Diluted Shares Outstanding | -- | -- | -- | 0.73% | 0.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |